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Abstract 
Infectious diseases remain a major health concern in many parts of the developing world, where access to adequate health care and modern 
diagnostic tools are absent. Current diagnostic technologies like ELISA and PCR require large sample volumes, bulky, expensive 
instrumentation, highly trained personnel, long experimental time, and a modern infrastructure that developing countries lack. Hence, portable, 
low cost tools would be a huge first step towards making accurate diagnostics available to a wider range of patients worldwide. In this work, 
we present a portable, microfluidic platform, controlled via a smartphone application, that requires no external pumping and is capable of rapid 
(within 18 minutes) 6-step colorimetric detection of an array of vaccinia virus proteins spotted on a nitrocellulose pad. We envision this 
platform as a first step to a fully integrated, portable immunoassay that can be used to expand global healthcare. 
© 2016 The Authors. Published by Elsevier B.V. 
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1. Introduction 
The ability to diagnose infected individuals is the first step to track and prevent the spread of infectious diseases. Due in large 
part to the availability of modern diagnostic techniques, routine testing and access to quality healthcare, less than 5% of deaths in 
developed countries are due to infectious diseases. In developing countries, a lack of a modern healthcare infrastructure, 
electricity, and clean water [1] causes this statistic to jump to 80%. The current state of the art for disease diagnosis includes 
enzyme-linked immunosorbent assays (ELISA) and polymerase chain reaction (PCR), both of which are time consuming and 
require large, expensive equipment operated by highly trained personnel [1]. Many developing countries do not have the 
resources, infrastructure, or personnel to handle facilities needed to maintain and run such equipment. Thus, biological fluid 
samples that are collected in remote locations of these countries need to be stored and shipped elsewhere for analysis, where 
sample degradation and storage conditions are a major limiting factor [1].  With the advent of microfluidic technologies, there has 
been an increased focus on developing miniaturized, simple, and low power diagnostic tools that can be used in the field to 
expand access to healthcare globally.  Since microfluidics also offers the advantage of using small sample and reagent volumes, 
cost and assay time are reduced dramatically.  
Unfortunately, much of the technology that has been developed to integrate ELISA or PCR into a microfluidic platform still 
requires bulky, expensive external pumping sources or equipment that can limit portability [2, 3]. Some attempts have been made 
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to integrate pumping on-chip but they suffer from inherent challenges to implement in the field. For example, Gao et al. [4] 
devised a 26 minute assay that used electro-osmosis for sample transportation via pH changes, and fluorescence for detection. 
Continuous voltage changes are needed for due to different pH of different samples makes the system unreliable for antigen 
surface binding, and fluorescent detection requires additional expensive equipment.  Sista et al. [5] utilized electrowetting to 
manipulate sample and reagent droplets in the presence an electric field applied via on on-chip micro-electrode array and 
chemiluminescence for detection. The assay took 7 minutes to complete, but suffered from low throughput in terms of the 
number of antigens tested per experiment.  Micropneumatic pumping by Wang et al. [6], used compressed air and deformable 
membranes to displace fluid. However, this method required precision control of valve membranes thickness and operation, 
adding fabrication complexity. Centrifugal force has also been successfully used by Madou et al. [7] for reagent delivery on a CD 
based platforms, with several commercial products already on the market [8]. Although centrifugal methods are quite developed, 
the technology requires a rotary system and on disc valves which adds fabrication complexity. Power free transport by Hosokawa 
et al. [9] used air evacuation and performed the an assay within 20 minutes, but suffered from throughput, once again with 
respect to number of antigens detected.  
Considering the requirement of an efficient pumping system that is easy to fabricate, high throughput, reduced assay time and 
inexpensive, portable equipment, our group has utilized the LCATs[10, 11] to achieve pumping via cavity-induced 
microstreaming in a microfluidic platform, negating the need for external pumps. The LCATs can be activated via a small, low 
power PZT controlled via a smartphone android application.  The device is integrated with a nitrocellulose pad that has an array 
of printed antigen spots specific for a particular disease-causing organism.  Serum from a person infected with this particular 
organism contains antibodies that will bind to these spots. The antibodies are then tagged with a secondary antibody that can 
provide a visual output (colorimetric) to quantify antibody concentration and patient infection. VCATs were integrated in the 
device above the nitrocellulose pads to promote mixing and reduce assay time (Fig 1a, b). 
 
Nomenclature 
LCAT: Lateral Cavity Acoustic Transducers 
VCAT: Vertical Cavity Acoustic Transducers 
PZT: Piezoelectric Transducer 
2. Materials and Methods 
The microfluidic device was made with Polydimethylsiloxane (PDMS, Sylgard) using standard ultraviolet (UV) 
photolithographic techniques [12]. Briefly, the two layered SU-8 mold was fabricated by spin-coating SU-8 2050 negative 
photoresist to a desired thickness, pre-baking, UV exposure for 23sec, post baking the first layer and spin coating followed by 
pre-baking the resist for second layer. This was then aligned with the second layer mask using a mask-aligner (MA56). This 
second layer was exposed to UV light for 16sec and the master mold was then post baked and developed using SU-8 developer. 
The same mold was silanized and kept in a vacuum dessicator overnight. The two components of PDMS, base and curing agent 
were mixed in the ratio of 11.5:1 and mixed well until the mixture became opaque with bubbles. This was poured on the mold 
and kept in a vacuum desiccator to remove bubbles. The mold was then placed in a 65ᵒC oven to cure overnight and peeled using 
sharp tweezers once cured. The height of the microchannel was 100ρm and the width of the main channel was 500ρm. It has 
been shown that the best efficiency of pumping was given by the LCATs when placed at an angle of 15ᵒ relative to main channel 
[11]. The LCAT side channels were 100ρm wide and 500ρm long while the VCAT mixers were 100ρm in diameter spaced 
200ρm from center-to-center. The design specifications were chosen for the optimal mixing as demonstrated in previous work 
[13]. The inlet hole was made with a 4mm punch and the outlet with a 1.5 mm punch. The nitrocellulose pad is 6.5mm long and 
6.5mm wide and is placed in a square shaped chamber with two 1.5mm bubble vents punched at the diagonals. The PDMS 
device is bonded on the glass slide containing the spot bearing nitrocellulose pad using a spray-on hydrophobic coating by Rain-
X. Compared to a hexagonal shape, the square shaped chamber is better for relieving air trapped in the device during priming 
[14].The dimensions of the device are shown in Fig. 1c. 
3. Results and Discussion 
Pumping and fluid transport are major challenges to overcome for portable microfluidic devices. To enable a portable 
diagnostic device, a pumping mechanism which is easy to fabricate, simple to operate, low cost, and compatible with biological 
samples is ideal. Our lab has previously demonstrated the coupling of air bubbles with acoustic microstreaming to transfer or mix 
fluid within a microfluidic device [10]. Acoustic microstreaming uses sound waves to actuate and oscillate an air bubble. The 
microfluidic chip is placed onto a PZT, which provides the acoustic energy. A function generator energizes the PZT with an 
alternating square wave. When the square wave is set to the resonant frequency of the air cavity features, the air-liquid interfaces 
oscillate rapidly and creates eddies in the nearby fluid.  
These cavities can produce either pumping or mixing when placed adjacent to a fluid channel. When the cavities are placed at 
an angle relative to the main channel, a pumping effect is observed (Fig 1c). These angled features are termed as LCATs. When 
the cavities are placed perpendicular to a fluid channel, mixing is observed in the fluid (Fig 1b). The perpendicular cavity feature 
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is termed as a VCAT. We have incorporating both mechanisms in our device for the pumping, mixing and hybridization of 
various reagents on a nitrocellulose pad.  
 
Figure 1: LCAT and VCAT illustrations. a) VCATs on the top of nitrocellulose pad. b) Side View of the actuated VCATs in the PDMS device. c) Net flow along 
with microstreaming vortices in the LCATs. d) Top-View of the chip bonded on rain-ex coated glass slide 
 
The LCAT chip can be operated in the lab using a function generator (Agilent 33220, Agilent Technologies) and a voltage 
amplifier (Krohn-Hite 7500, Krohn-Hite Corp.). These benchtop devices are bulky, and difficult to transport. In this paper, a 
prototype for a portable device is demonstrated. The primary function of the device is to actuate the PZT (Steiner & Martins Inc.) 
with a desired frequency and voltage. An Arduino microcontroller is used as the primary controller in the device, which is 
powered by a rechargeable lithium ion battery, and can communicate with a smart phone using a Bluetooth receiver. The battery 
can power a single PZT continuously for up to three hours (Fig 2a).  
An android application, running on a smart phone, was used to control the portable device. The application used in this 
demonstration was created using the MIT App Inventor [15], a software tool easily accessible to all engineers. The application 
shown in (Fig 2b, c) is designed to drive up to six PZT devices. Through the android application, a wide range of frequencies and 
voltages can be selected to drive the PZT. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: The prototype circuit driving an LCAT chip. a) Project enclosure (left), breadboard circuit (center), and PZT with LCAT Chip (right). b) Screen shots 
of the android application are shown. On and Off control for up to six PZT’s. c) Configurable frequency options (right) 
Once activated, the microcontroller outputs a square wave signal at 5Vpp. The signal is passed from the microcontroller to an 
operational amplifier (Op-Amp AD 844), where it can be scaled up or down using a variable resistor in the feedback loop. The 
operational amplifier chosen was selected for its high slew rate, which allows operation at high frequency. In addition, this 
specific operational amplifier is also capable of driving the highly capacitive PZT. The output of the operational amplifier is 
supplied directly to the PZT, which in turn actuates the air cavities trapped in each LCAT and VCAT. 
Two-hundred-ten vaccinia virus genes were amplified by PCR and inserted into the plasmid vector pXT7 by recombination in 
E. coli as previously described [16]. This method linked each vaccine open reading frame to an amino-terminal 6-His sequence 
and a carboxy-terminal influenza virus HA epitope. Doubly tagged proteins were expressed in an E.coli-based cell-free coupled 
in vitro transcription-translation reaction (Roche RTS 100 E. coli HY Kit). Subsequently, vaccinia virus proteins as well as 
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human and mouse IgG controls were printed on nitrocellulose-coated FAST slides (GE-Schleicher and Schuell) using an Omni 
Grid 100 microarray printer. A simple colorimetric assay was run within the microfluidic chip, with pumping promoted created 
by LCATs. Utilizing a Rain-X coating on the glass slide, the PDMS chip was reversibly bonded and held in place by the 
hydrophobic interaction between the two surfaces.  
While a similar bench top assay generally requires hours to obtain a result [16], the use of recirculating the reagents within the 
microfluidic device can cut the assay to time down to 45 minutes [17]. With the use of the vertical acoustic transducer (VCAT) 
design to promote mixing, the recirculation can be avoided, and the assay can be completed in as little as 18 minutes. 
To create the LCAT and VCAT interfaces, the device was initially primed with a blocking buffer (Antigen Discovery Inc.) 
with the careful use of a syringe. The priming step also served to hydrate the nitrocellulose pad and prevent non-specific binding. 
The first test was run using an external voltage amplifier and function generator that would be unsuitable for portability and 
field-testing. The output frequency and voltage was 49.8kHz and 6.5Vpp respectively. The chip was first probed with primary 
antibody (monoclonal Anti HA rat antibody, Roche USA) diluted to 1:1000 in blocking buffer, supplemented with 20% E. coli 
lysate for 5 min, secondary antibody (AP conjugated Goat α Rat Polyclonal IgG (H+L), Jackson, USA) diluted to 1:1000 in 
blocking buffer, supplemented with 2% E. coli lysate for 5 min with 1 min washing steps in between the introduction of each 
new reagent. The combination of NBT (nitro-blue tetrazolium chloride) and BCIP (5-bromo-4-chloro-3'-indolyphosphate p-
toluidine salt) yielded an intense, insoluble black-purple precipitate when reacted with alkaline phosphatase conjugated with 
secondary antibody. This was washed with DI water in the last step for 1 min and the pad was imaged with a phase contrast 
microscope.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Phase Contrast Microscopic Image of Spotted pads. a) 1:50 and b) 1:100 dilution of primary and secondary antibodies driven by android app. c) 1:1000 
dilution of primary and secondary antibodies combination driven by function generator 
 
The results of this test are displayed in Figure 3c, where a few spots can be seen to have reacted to the assay. The same test 
was repeated with higher antibody concentrations (1:100 and 1:50) and mixing of the original primary and secondary antibodies 
each with monoclonal anti-His mouse antibody (Sigma) and AP conjugated Goat α Mouse Polyclonal Fc ߛ ሺJacksonሻǡ 
respectively.  The android application and prototype circuit were used to drive the LCATs and VCATs. Even with the use of our 
portable configuration (Fig 2), the assay could still achieve spot reactivity within 18 minutes and showed more colored spots 
(Fig. 3a and 3b). The spot ids for Fig. 3a and 3b are shown in Table 1.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Plots of color intensity of the spots on the nitrocellulose pads. a) Intensity of the controls with decreasing concentration. b). Intensity comparison of the 
spots at 1:100 and 1:50 concentrations of antibody mixtures 
 
a) b) 
b) c) a) 
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We have plotted the color intensity of the selected spots, marked with asterisk in Table 1 using imageJ. The plot in Fig. 4b 
depicts the higher color intensity in the case of 1:50 dilution compared to 1:100. The graph in Fig. 4a shows the color intensity of 
the controls which are human immunoglobin G (hu-IgG) with decreasing concentration as well. As the concentration of controls 
decreases, the intensity reduces. Higher concentration of antibodies is needed for reduced time and volume operation and 
efficient transfer on the pad bearing antigen spots. 
 
Table 1. Spot IDs for the colored spots in Fig. 3a and 3b. *Quantitative analysis of the spots 
 
 
 
 
 
 
 
 
4. Conclusion 
A novel colorimetric immunoassay has been developed which makes use of on-chip pumping and does not require external 
pumps or complex mechanisms for fluid transfer. The assay is done within 18min using an android app, as compared to a similar 
bench-top assay which can take multiple hours. The sample preparation is practical as it requires separation of sera from the 
blood followed by its dilution in blocking buffer. Future work will demonstrate a more sensitive detection system for various 
infectious diseases such as HIV or HPV from sera extracted from whole blood in a portable setting, leading to a true point-of-
care device. 
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